ICOS gene polymorphisms in systemic lupus erythematosus: A case-control study.

Area of Science:

• Immunology
• Genetics
• Autoimmune Diseases

Background:

• The inducible T-cell costimulator (ICOS) is crucial for adaptive immunity, regulating T cell and antigen-presenting cell interactions.
• Disruption of ICOS function is implicated in autoimmune diseases, notably systemic lupus erythematosus (SLE).
• Understanding ICOS gene variations may reveal insights into SLE pathogenesis and susceptibility.

Purpose of the Study:

• To investigate the association between ICOS gene polymorphisms (rs11889031 and rs10932029) and SLE in a Tunisian population.
• To evaluate the influence of these polymorphisms on SLE susceptibility, clinical outcomes, and ICOS mRNA expression.
• To identify potential genetic biomarkers for SLE risk.

Main Methods:

• A case-control study involving 151 SLE patients and 291 healthy controls.
• Genotyping of ICOS gene polymorphisms rs11889031 and rs10932029 using PCR-RFLP, validated by sequencing.
• Quantitative PCR for ICOS mRNA expression analysis in peripheral blood mononuclear cells.

Main Results:

• A significant association was found between the ICOS rs11889031 CC genotype and increased SLE susceptibility (OR=2.44, p=0.0001).
• The rs11889031 TT genotype and T allele showed a protective effect against SLE (OR=0.08, p=0.016 and OR=0.43, p=7.69E-05, respectively).
• The rs11889031 CC genotype was linked to specific clinical manifestations, including blood pressure and anti-SSA antibodies, but no effect on ICOS mRNA levels was observed. The rs10932029 polymorphism showed no association with SLE.

Conclusions:

• The ICOS gene rs11889031 polymorphism, particularly the CC genotype, is a significant risk factor for SLE in the Tunisian population.
• The rs11889031 TT genotype demonstrates a protective role against SLE.
• ICOS rs11889031 may serve as a valuable genetic biomarker for SLE susceptibility.